Yantai Dongcheng Pharmaceutical Group Co.,Ltd.
002675.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | CN¥2,869 | CN¥3,276 | CN¥3,583 | CN¥3,912 |
| % Growth | -12.4% | -8.6% | -8.4% | – |
| Cost of Goods Sold | CN¥1,521 | CN¥1,922 | CN¥2,051 | CN¥2,324 |
| Gross Profit | CN¥1,348 | CN¥1,354 | CN¥1,532 | CN¥1,588 |
| % Margin | 47% | 41.3% | 42.8% | 40.6% |
| R&D Expenses | CN¥299 | CN¥197 | CN¥164 | CN¥138 |
| G&A Expenses | CN¥303 | CN¥239 | CN¥211 | CN¥203 |
| SG&A Expenses | CN¥719 | CN¥748 | CN¥778 | CN¥795 |
| Sales & Mktg Exp. | CN¥415 | CN¥509 | CN¥567 | CN¥593 |
| Other Operating Expenses | CN¥109 | CN¥67 | CN¥143 | CN¥298 |
| Operating Expenses | CN¥1,127 | CN¥1,012 | CN¥1,084 | CN¥1,231 |
| Operating Income | CN¥221 | CN¥342 | CN¥448 | CN¥357 |
| % Margin | 7.7% | 10.4% | 12.5% | 9.1% |
| Other Income/Exp. Net | -CN¥2 | -CN¥4 | -CN¥3 | -CN¥1 |
| Pre-Tax Income | CN¥219 | CN¥337 | CN¥446 | CN¥356 |
| Tax Expense | CN¥78 | CN¥83 | CN¥93 | CN¥95 |
| Net Income | CN¥184 | CN¥210 | CN¥307 | CN¥152 |
| % Margin | 6.4% | 6.4% | 8.6% | 3.9% |
| EPS | 0.223 | 0.254 | 0.38 | 0.189 |
| % Growth | -12.4% | -33.1% | 101.2% | – |
| EPS Diluted | 0.223 | 0.254 | 0.38 | 0.189 |
| Weighted Avg Shares Out | 825 | 825 | 808 | 802 |
| Weighted Avg Shares Out Dil | 825 | 825 | 808 | 802 |
| Supplemental Information | – | – | – | – |
| Interest Income | CN¥6 | CN¥13 | CN¥13 | CN¥5 |
| Interest Expense | CN¥98 | CN¥59 | CN¥62 | CN¥59 |
| Depreciation & Amortization | CN¥150 | CN¥138 | CN¥120 | CN¥115 |
| EBITDA | CN¥433 | CN¥512 | CN¥672 | CN¥728 |
| % Margin | 15.1% | 15.6% | 18.8% | 18.6% |